Lappe Mark
SEC CIK 1366074 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| INBX | Inhibrx Biosciences, Inc. | CEO, Dir | 730.5K | $5.06M | — | 6 | 2024-05-29 | 2026-09-08 |
Most active insiders at INBX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Viking Global Opportunities Parent GP LLC | 10% | — | $11.29M |
| 2 | Lappe Mark | CEO, Dir | $2.65M | — |
| 3 | Kayyem Jon Faiz | Dir | $1.57M | — |
| 4 | FORSYTH DOUGLAS | Dir | $286.6K | — |
| 5 | MANHARD KIMBERLY | Dir | — | $279.0K |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-09-08 16:04 | 2026-09-08 | INBX | Inhibrx Biosciences, Inc. | Lappe Mark | CEO, Dir | P - Purchase | $105.82 | +25.0K | 730.5K | +4% | +$2.65M |
| MI | 2024-09-16 | 2024-09-12+ | INBX | Inhibrx Biosciences, Inc. | Lappe Mark | CEO, Dir | P - Purchase | $15.73 | +40.0K | 692.5K | +6% | +$629.1K |
| MI | 2024-09-10 | 2024-09-06+ | INBX | Inhibrx Biosciences, Inc. | Lappe Mark | CEO, Dir | P - Purchase | $15.25 | +44.0K | 647.5K | +7% | +$671.1K |
| MI | 2024-09-03 | 2024-08-29+ | INBX | Inhibrx Biosciences, Inc. | Lappe Mark | CEO, Dir | P - Purchase | $14.92 | +40.0K | 135.0K | +42% | +$596.8K |
| MI | 2024-08-22 | 2024-08-20+ | INBX | Inhibrx Biosciences, Inc. | Lappe Mark | CEO, Dir | P - Purchase | $12.96 | +40.0K | 54.9K | +269% | +$518.3K |
| DMI | 2024-05-30 | 2024-05-29 | INBX | Inhibrx Biosciences, Inc. | Lappe Mark | CEO, Dir | A - Grant | — | +761.4K | 621.5K | New | — |
Purchase Sale Sale after option exercise All abbreviations